HC Wainwright maintains $8.00/share price target on MIST
HC Wainwright & Co. maintained its $8.00 per share price target for Milestone Pharmaceuticals, according to Benzinga ratings actions.
Find public news by keyword, exact ticker, category and date.
Open a ticker page for its news coverage. The news search below stays a text search.
1 result loaded, newest first. End of these results.
HC Wainwright & Co. maintained its $8.00 per share price target for Milestone Pharmaceuticals, according to Benzinga ratings actions.